Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System

Immunity

Volumn 43, Issue 6, 2015, Pages 1174-1185

  Guerrini, Matteo M ^a,b   Okamoto, Kazuo ^a,b   Komatsu, Noriko ^a   Sawa, Shinichiro ^a,b   Danks, Lynett ^a,b   Penninger, Josef M ^c   Nakashima, Tomoki ^b,d   Takayanagi, Hiroshi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; AS 2676293; BETA1 INTEGRIN; CHEMOKINE RECEPTOR CXCR3; IMMUNOMODULATING AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 23; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; TNFSF11 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL ADHESION; CELL MIGRATION; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOPATHOGENESIS; MOUSE; NEUROPATHOLOGY; NONHUMAN; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPINAL CORD; T LYMPHOCYTE; TH17 CELL; ANIMAL; COCULTURE; DEFICIENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; NEUTROPHIL CHEMOTAXIS; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ASTROCYTES; CHEMOTAXIS, LEUKOCYTE; COCULTURE TECHNIQUES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; RANK LIGAND; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 84949643857     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.10.017     Document Type: Article

References (36)

1. Akiyama T., Shimo Y., Yanai H., Qin J., Ohshima D., Maruyama Y., Asaumi Y., Kitazawa J., Takayanagi H., Penninger J.M., et al. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity 2008, 29:423-437.
2. Ambrosini E., Columba-Cabezas S., Serafini B., Muscella A., Aloisi F. Astrocytes are the major intracerebral source of macrophage inflammatory protein-3α/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia 2003, 41:290-300.
3. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., Teepe M.C., DuBose R.F., Cosman D., Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997, 390:175-179.
4. Arima Y., Harada M., Kamimura D., Park J.H., Kawano F., Yull F.E., Kawamoto T., Iwakura Y., Betz U.A., Márquez G., et al. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 2012, 148:447-457.
5. Ashcroft A.J., Cruickshank S.M., Croucher P.I., Perry M.J., Rollinson S., Lippitt J.M., Child J.A., Dunstan C., Felsburg P.J., Morgan G.J., Carding S.R. Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. Immunity 2003, 19:849-861.
6. Bachmann M.F., Wong B.R., Josien R., Steinman R.M., Oxenius A., Choi Y. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J. Exp. Med. 1999, 189:1025-1031.
7. Bartholomäus I., Kawakami N., Odoardi F., Schläger C., Miljkovic D., Ellwart J.W., Klinkert W.E., Flügel-Koch C., Issekutz T.B., Wekerle H., Flügel A. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009, 462:94-98.
8. Bauer M., Brakebusch C., Coisne C., Sixt M., Wekerle H., Engelhardt B., Fässler R. β1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity. Proc. Natl. Acad. Sci. USA 2009, 106:1920-1925.
9. Cummings S.R., San Martin J., McClung M.R., Siris E.S., Eastell R., Reid I.R., Delmas P., Zoog H.B., Austin M., Wang A., et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N. Engl. J. Med. 2009, 361:756-765. FREEDOM Trial.
10. de Boer J., Williams A., Skavdis G., Harker N., Coles M., Tolaini M., Norton T., Williams K., Roderick K., Potocnik A.J., Kioussis D. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 2003, 33:314-325.
11. Engelhardt B., Ransohoff R.M. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012, 33:579-589.
12. Fukumoto N., Shimaoka T., Fujimura H., Sakoda S., Tanaka M., Kita T., Yonehara S. Critical roles of CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in the pathogenesis of both acute and adoptive transfer experimental autoimmune encephalomyelitis. J. Immunol. 2004, 173:1620-1627.
13. Ganat Y.M., Silbereis J., Cave C., Ngu H., Anderson G.M., Ohkubo Y., Ment L.R., Vaccarino F.M. Early postnatal astroglial cells produce multilineage precursors and neural stem cells in vivo. J. Neurosci. 2006, 26:8609-8621.
14. + Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 2002, 16:183-191.
15. Hanada R., Leibbrandt A., Hanada T., Kitaoka S., Furuyashiki T., Fujihara H., Trichereau J., Paolino M., Qadri F., Plehm R., et al. Central control of fever and female body temperature by RANKL/RANK. Nature 2009, 462:505-509.
16. Hikosaka Y., Nitta T., Ohigashi I., Yano K., Ishimaru N., Hayashi Y., Matsumoto M., Matsuo K., Penninger J.M., Takayanagi H., et al. The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. Immunity 2008, 29:438-450.
17. Inoue M., Williams K.L., Gunn M.D., Shinohara M.L. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2012, 109:10480-10485.
18. Josien R., Li H.L., Ingulli E., Sarma S., Wong B.R., Vologodskaia M., Steinman R.M., Choi Y. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J. Exp. Med. 2000, 191:495-502.
19. Kang Z., Altuntas C.Z., Gulen M.F., Liu C., Giltiay N., Qin H., Liu L., Qian W., Ransohoff R.M., Bergmann C., et al. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 2010, 32:414-425.
20. Kim J.K., Jin X., Sohn Y.W., Jin X., Jeon H.Y., Kim E.J., Ham S.W., Jeon H.M., Chang S.Y., Oh S.Y., et al. Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling. Cancer Lett. 2014, 353:194-200.
21. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A.J., Van G., Itie A., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 397:315-323.
22. Laschinger M., Engelhardt B. Interaction of α4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro. J. Neuroimmunol. 2000, 102:32-43.
23. Loser K., Mehling A., Loeser S., Apelt J., Kuhn A., Grabbe S., Schwarz T., Penninger J.M., Beissert S. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 2006, 12:1372-1379.
24. Meares G.P., Ma X., Qin H., Benveniste E.N. Regulation of CCL20 expression in astrocytes by IL-6 and IL-17. Glia 2012, 60:771-781.
25. Miyata J., Kasahara C., Asano T., Ito S., Seki N., Kato Y., Morikawa N., Nozaki K., Nishimura K., Akamatsu H., et al. Orally available pyridinylpyrimidine derivatives as novel RANKL-induced osteoclastogenesis inhibitors. Bioorg. Med. Chem. Lett. 2012, 22:5681-5684.
26. Nakashima T., Hayashi M., Fukunaga T., Kurata K., Oh-Hora M., Feng J.Q., Bonewald L.F., Kodama T., Wutz A., Wagner E.F., et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 2011, 17:1231-1234.
27. Pelletier D., Hafler D.A. Fingolimod for multiple sclerosis. N. Engl. J. Med. 2012, 366:339-347.
28. Ransohoff R.M. Natalizumab for multiple sclerosis. N. Engl. J. Med. 2007, 356:2622-2629.
29. Ransohoff R.M., Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 2012, 12:623-635.
30. H-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 2009, 10:514-523.
31. Rothhammer V., Heink S., Petermann F., Srivastava R., Claussen M.C., Hemmer B., Korn T. Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE. J. Exp. Med. 2011, 208:2465-2476.
32. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 2006, 203:2673-2682.
33. Vajkoczy P., Laschinger M., Engelhardt B. α4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 2001, 108:557-565.
34. Williamson E., Bilsborough J.M., Viney J.L. Regulation of mucosal dendritic cell function by receptor activator of NF-κ B (RANK)/RANK ligand interactions: impact on tolerance induction. J. Immunol. 2002, 169:3606-3612.
35. Wong B.R., Josien R., Lee S.Y., Sauter B., Li H.L., Steinman R.M., Choi Y. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 1997, 186:2075-2080.
36. Zúñiga L.A., Jain R., Haines C., Cua D.J. Th17 cell development: from the cradle to the grave. Immunol. Rev. 2013, 252:78-88.